PSUSA/00010289/202402
Submitted by Anonymous (not verified) on 3 October 2024 - 15:33
PSUSA/00010289/202402
PSUSA/00002217/202402
Submitted by Anonymous (not verified) on 3 October 2024 - 15:31
PSUSA/00002217/202402
PSUSA/00010298/202403
Submitted by Anonymous (not verified) on 3 October 2024 - 15:30
PSUSA/00010298/202403
PSUSA/00002181/202401
Submitted by Anonymous (not verified) on 3 October 2024 - 15:27
PSUSA/00002181/202401
PSUSA/00001400/202402
Submitted by Anonymous (not verified) on 3 October 2024 - 15:24
PSUSA/00001400/202402
PSUSA/00001744/202403
Submitted by Anonymous (not verified) on 3 October 2024 - 15:23
PSUSA/00001744/202403
QRD statements for metered dose inhalers containing fluorinated greenhouse gases
Submitted by Anonymous (not verified) on 3 October 2024 - 15:10
QRD statements for metered dose inhalers containing fluorinated greenhouse gases
PSUSA/00000197/202402
Submitted by Anonymous (not verified) on 3 October 2024 - 15:02
PSUSA/00000197/202402
Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers
Submitted by Anonymous (not verified) on 3 October 2024 - 15:02
Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers
Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 3 October 2024 - 12:56
Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision: 4, Status: Authorised